Global Bladder Cancer Pipeline Report 2016 - Review of 94 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Bladder Cancer - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Bladder Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bladder Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

Introduction

Bladder Cancer Overview

Therapeutics Development

Pipeline Products for Bladder Cancer - Overview

Pipeline Products for Bladder Cancer - Comparative Analysis

Bladder Cancer - Therapeutics under Development by Companies

Bladder Cancer - Therapeutics under Investigation by Universities/Institutes

Bladder Cancer Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Bladder Cancer - Products under Development by Companies

Bladder Cancer - Products under Investigation by Universities/Institutes

Bladder Cancer - Companies Involved in Therapeutics Development

  1. 4SC AG
  • ADC Therapeutics Sarl
  • Advaxis, Inc.
  • Agenus, Inc.
  • Alligator Bioscience AB
  • Alnylam Pharmaceuticals, Inc.
  • Altor BioScience Corporation
  • AndroScience Corporation
  • APIM Therapeutics AS
  • Arno Therapeutics, Inc.
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • AVEO Pharmaceuticals, Inc.
  • Azaya Therapeutics, Inc.
  • Bavarian Nordic A/S
  • Bayer AG
  • BioCancell Ltd
  • Biomics Biotechnologies Co., Ltd.
  • Bioncotech Therapeutics S.L.
  • Biotest AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Cellceutix Corporation
  • Celldex Therapeutics, Inc.
  • Cold Genesys, Inc.
  • Corvus Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Limited
  • DormaTarg, Inc.
  • Eisai Co., Ltd.
  • enGene, Inc
  • Esperance Pharmaceuticals, Inc.
  • Evotec AG
  • Exelixis, Inc.
  • F. Hoffmann-La Roche Ltd.

For more information visit http://www.researchandmarkets.com/research/hqx6jp/bladder_cancer

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Bladder Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Bladder Cancer Drugs